B. N. Prashanth Kumar

Author

Indian Institute of Technology Kharagpur

Also Known As

B Kumar, B N Prashanth Kumar, B. Kumar, B. N. Prashanth Kumar, B. kumar, B.N. Prashanth Kumar

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Indian Institute of Technology Kharagpur Virginia Commonwealth University The University of Texas MD Anderson Cancer Center Dalhousie University

About

B. N. Prashanth Kumar is an author at Indian Institute of Technology Kharagpur specializing in medicine, radiation oncology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1K
2	Engineering	12	12	998
3	Biomedical Engineering	9	9	711
4	Health Sciences	2	2	146
5	Biomolecular Engineering	2	2	260

B. N. Prashanth Kumar

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer P. Venkatesan, Nagaprasad Puvvada, Rupesh Dash, Biomaterials NanomedicineEngineeringPolymer-drug ConjugateTherapeutic NanomaterialsNano-drug Delivery	2011	255
Synthesis of biocompatible multicolor luminescent carbon dots for bioimaging applications Nagaprasad Puvvada, B. N. Prashanth Kumar, Suraj Konar, Science and Technology of Advanced Materials NanoparticlesNanomedicineChemical EngineeringSulfuric AcidFourier Transform	2012	182
Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells Shashi Rajput, B. N. Prashanth Kumar, Kaushik Dey, Life Sciences Chemoprevention StrategyTranslation InhibitionApoptosisCell DeathThymoquinone Promotes G1	2013	140
Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer Goutam Dey, Rashmi Bharti, Gunaseelan Dhanarajan, Scientific Reports	2015	126
Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer Shashi Rajput, B. N. Prashanth Kumar, Siddik Sarkar, PLoS ONE Breast OncologyChemoprevention StrategyApoptosis ProteinApoptosisImmunology	2013	117
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo Aditya Parekh, Subhayan Das, Sheetal Parida, Oncogene Tumor BiologyBreast OncologyOncologyMedicineBreast Cancer	2018	98
N-doped carbon dot as fluorescent probe for detection of cysteamine and multicolor cell imaging Suraj Konar, B. N. Prashanth Kumar, Madhusudan Kr. Mahto, Sensors and Actuators B Chemical Fluorescence MicroscopyEngineeringMicroscopyNovel Imaging MethodBiomedical Imaging	2019	97
Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression Nagaprasad Puvvada, Shashi Rajput, B. N. Prashanth Kumar, Scientific Reports NanotherapeuticsEngineeringBiomedical EngineeringTumor BiologyNanomedicine	2015	91
Photoresponsive Coumarin-Tethered Multifunctional Magnetic Nanoparticles for Release of Anticancer Drug Nagaprasad Puvvada, B. N. Prashanth Kumar, Shashi Rajput, ACS Applied Materials & Interfaces NanoparticlesEngineeringBiomedical EngineeringProtein NanoparticlesNanomedicine	2013	90
Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy Rashmi Bharti, Goutam Dey, Indranil Banerjee, Cancer Letters Breast OncologyImmunologyBreast Cancer TherapyBreast CancerTumor Targeting	2016	79

Page 1